In the current clinical practice, there are many serologic studies to aid in the diagnosis of CeD which include autoantibodies like IgA antitissue transglutaminase (tTG), antiendomysial antibody (EMA), and antideamidated forms of gliadin peptide antibodies (DGP) [12]. Here, TGM2 is linked to cranioectodermal dysplasia.